![](/img/cover-not-exists.png)
1301PDThree-year follow-up from CheckMate 017/057: Nivolumab versus docetaxel in patients with previously treated advanced non-small cell lung cancer (NSCLC)
Felip Font, E., Gettinger, S.N., Burgio, M.A., Antonia, S.J., Holgado, E., Spigel, D.R., Arrieta, O., Domine Gomez, M., Aren Frontera, O., Brahmer, J., Chow, L.Q., Crinò, L., Butts, C., Coudert, B., HVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx380.004
Date:
September, 2017
File:
PDF, 69 KB
english, 2017